标题
Elimination of established tumors with nanodisc-based combination chemoimmunotherapy
作者
关键词
-
出版物
Science Advances
Volume 4, Issue 4, Pages eaao1736
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2018-04-19
DOI
10.1126/sciadv.aao1736
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effect of size and pegylation of liposomes and peptide-based synthetic lipoproteins on tumor targeting
- (2017) Jie Tang et al. Nanomedicine-Nanotechnology Biology and Medicine
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- ZnO-Based Nanoplatforms for Labeling and Treatment of Mouse Tumors without Detectable Toxic Side Effects
- (2016) Dai-Xin Ye et al. ACS Nano
- High-Density Lipoproteins: Nature’s Multifunctional Nanoparticles
- (2016) Rui Kuai et al. ACS Nano
- Management of toxicities of immune checkpoint inhibitors
- (2016) Lavinia Spain et al. CANCER TREATMENT REVIEWS
- Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
- (2016) Christina Pfirschke et al. IMMUNITY
- Synthetic high-density lipoproteins for delivery of 10-hydroxycamptothecin
- (2016) Yue Yuan et al. International Journal of Nanomedicine
- Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
- (2016) Jonathan E Rosenberg et al. LANCET
- Designer vaccine nanodiscs for personalized cancer immunotherapy
- (2016) Rui Kuai et al. NATURE MATERIALS
- Anti-PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM
- (2016) D. Mathios et al. Science Translational Medicine
- Local and transient gene expression primes the liver to resist cancer metastasis
- (2016) T. J. Goodwin et al. Science Translational Medicine
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Synthetic high-density lipoprotein nanoparticles: A novel therapeutic strategy for adrenocortical carcinomas
- (2016) Chitra Subramanian et al. SURGERY
- A PEGylation-Free Biomimetic Porphyrin Nanoplatform for Personalized Cancer Theranostics
- (2015) Liyang Cui et al. ACS Nano
- The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory properties
- (2015) Anna Schwendeman et al. JOURNAL OF LIPID RESEARCH
- Mutant MHC class II epitopes drive therapeutic immune responses to cancer
- (2015) Sebastian Kreiter et al. NATURE
- Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
- (2015) Christina Twyman-Saint Victor et al. NATURE
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Doxil Synergizes with Cancer Immunotherapies to Enhance Antitumor Responses in Syngeneic Mouse Models
- (2015) Jonathan Rios-Doria et al. NEOPLASIA
- Vaccine-Induced Tumor Necrosis Factor-Producing T Cells Synergize with Cisplatin to Promote Tumor Cell Death
- (2014) T. C. van der Sluis et al. CLINICAL CANCER RESEARCH
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- (2014) Matthew M. Gubin et al. NATURE
- Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
- (2014) Mahesh Yadav et al. NATURE
- Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
- (2014) Antonella Sistigu et al. NATURE MEDICINE
- HDL-targeted therapies: progress, failures and future
- (2014) Bronwyn A. Kingwell et al. NATURE REVIEWS DRUG DISCOVERY
- Focal Radiation Therapy Combined with 4-1BB Activation and CTLA-4 Blockade Yields Long-Term Survival and a Protective Antigen-Specific Memory Response in a Murine Glioma Model
- (2014) Zineb Belcaid et al. PLoS One
- A unique squalenoylated and nonpegylated doxorubicin nanomedicine with systemic long-circulating properties and anticancer activity
- (2014) A. Maksimenko et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CCL2/CCR2-Dependent Recruitment of Functional Antigen-Presenting Cells into Tumors upon Chemotherapy
- (2013) Yuting Ma et al. CANCER RESEARCH
- Chemotherapy Acts as an Adjuvant to Convert the Tumor Microenvironment into a Highly Permissive State for Vaccination-Induced Antitumor Immunity
- (2013) T. H. Kang et al. CANCER RESEARCH
- Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors
- (2013) J. Duraiswamy et al. CANCER RESEARCH
- Development and characterization of a reliable mouse model of colorectal cancer metastasis to the liver
- (2013) Yu Zhang et al. CLINICAL & EXPERIMENTAL METASTASIS
- Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells
- (2013) Yuting Ma et al. IMMUNITY
- Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma
- (2013) Nienke van Rooij et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- BiVax: a peptide/poly-IC subunit vaccine that mimics an acute infection elicits vast and effective anti-tumor CD8 T-cell responses
- (2012) Hyun-Il Cho et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- HPMA copolymer-doxorubicin conjugates: The effects of molecular weight and architecture on biodistribution and in vivo activity
- (2012) Tomáš Etrych et al. JOURNAL OF CONTROLLED RELEASE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk
- (2009) M.T. Cooney et al. ATHEROSCLEROSIS
- Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis
- (2009) Miguel A. Frias et al. CARDIOVASCULAR RESEARCH
- Self-assembling chimeric polypeptide–doxorubicin conjugate nanoparticles that abolish tumours after a single injection
- (2009) J. Andrew MacKay et al. NATURE MATERIALS
- Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
- (2009) François Ghiringhelli et al. NATURE MEDICINE
- In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: Involvement of cytotoxic effect on vascular endothelial cells
- (2008) Ken-ichi Ogawara et al. JOURNAL OF CONTROLLED RELEASE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started